Enzymatic Characterization of the Pancreatic Islet-specific Glucose-6-Phosphatase-related Protein (IGRP)

Anthony J. Petrolonis(Millennium Engineering and Integration (United States)), Suk-Bong Hong(Texas A&M University), Lin Ge(Tsinghua University), Thomas F. Parsons(Millennium Engineering and Integration (United States)), Sadhana Jain(Millennium Engineering and Integration (United States)), Wei An(Millennium Engineering and Integration (United States)), Qing Yang(Université de Montréal), Peter J. Tummino(Millennium Engineering and Integration (United States)), Steven Langston(Takeda (United States)), Natalie A. Dales(Millennium Engineering and Integration (United States)), Andrea E. Prack(Millennium Engineering and Integration (United States)), Hong Chen(Millennium Engineering and Integration (United States)), Ping Li(Anhui Medical University), Alwin G. Schuller(AstraZeneca (South Korea)), Louis A. Tartaglia(Millennium Engineering and Integration (United States)), Susan Fish(Millennium Engineering and Integration (United States))
Journal of Biological Chemistry
March 26, 2004
10.1074/jbc.m307756200
Cited by 55

Related Papers

An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
|Nature|2009|2k
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974
|Proceedings of the National Academy of Sciences|2013|833
Substrate-Assisted Inhibition of Ubiquitin-like Protein-Activating Enzymes: The NEDD8 E1 Inhibitor MLN4924 Forms a NEDD8-AMP Mimetic In Situ
|Molecular Cell|2010|461
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
|Nature Medicine|2018|453
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB–dependent lymphoma
|Blood|2010|323